Latest Us Expansion News

Australian Strategic Materials has successfully raised A$13 million through an institutional placement, complementing an oversubscribed Share Purchase Plan to total nearly A$25 million. These funds will accelerate ASM’s metallisation expansion in the US and ramp up production at its Korean Metals Plant.

Singular Health has landed a pivotal $2 million US pilot contract with Provider Network Solutions and completed an $8 million capital raise, advancing its medical imaging platform’s regulatory and product development milestones.

Echo IQ has secured a strategic collaboration with the Mayo Clinic Platform and raised $17.3 million, advancing its AI-driven cardiology tools towards FDA clearance and US commercial scale.

Titomic has launched a major US manufacturing hub in Alabama, secured key defense contracts, and expanded leadership to accelerate its global additive manufacturing ambitions.

Argenica Therapeutics has dosed the final patient in its Phase 2 trial for ARG-007 in acute ischaemic stroke, with topline results expected in Q3 2025. Meanwhile, the FDA has placed a clinical hold on its US trial application, introducing uncertainty for US development.

Australian Strategic Materials (ASM) reports significant progress in Q2 2025, including its first commercial heavy rare earth metals sale and a transformative low-cost production pathway at its Dubbo Project.

BetMakers Technology Group capped FY25 with its strongest quarterly results ever, showcasing record profitability, positive cash flow, and a debt-free balance sheet. The company’s strategic investments and recent capital raise set the stage for accelerated growth in FY26, including a key acquisition in Nevada.

Australian Strategic Materials has closed its Share Purchase Plan substantially oversubscribed, raising nearly four times its target to accelerate key growth projects including US expansion and ramping up its Korean Metals Plant.

Adherium Limited has successfully completed a $4.49 million entitlement offer, combining institutional and retail components, to fund expansion of its Hailie® digital respiratory monitoring platform.

Proteomics International’s subsidiary OxiDx has unveiled a pioneering test that detects muscle damage in thoroughbred racehorses, promising to transform recovery management in the racing industry. The test’s commercial launch is slated for the second half of 2025.

Echo IQ has secured a pivotal reseller agreement with US-based SARC MedIQ, unlocking access to over 300 healthcare facilities and accelerating adoption of its AI-driven EchoSolv AS technology across the American cardiology landscape.

AML3D has received a pivotal Letter of Intent from the US Navy, outlining plans for additive manufacturing collaboration and significant demand growth through 2030.